Exacerbation Copd Clinical Trial
Official title:
Effects of Inspiratory Muscle Training in Addition to Pulmonary Rehabilitation in Patients With COPD Exacerbation
Verified date | February 2023 |
Source | National Taiwan University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Inspiratory muscle weakness, limited functional exercise capacity and worse quality of life have been shown in patients with exacerbation of chronic obstructive pulmonary disease (COPD). Recommendations from clinical practice guideline state that promoting pulmonary rehabilitation after exacerbation can improve the conditions above. Inspiratory muscle training (IMT) has been proven to enhance inspiratory muscle strength and endurance in patient with stable COPD. However, there is less research on whether IMT in addition to pulmonary rehabilitation after exacerbation can benefit inspiratory muscle function, functional exercise capacity and quality of life in patients with COPD. The purpose of this study is to examine the effects of IMT in addition to pulmonary rehabilitation on respiratory muscle function, functional exercise capacity and quality of life in patients with exacerbation of chronic obstructive pulmonary disease.
Status | Completed |
Enrollment | 16 |
Est. completion date | September 16, 2022 |
Est. primary completion date | September 16, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 20 Years and older |
Eligibility | Inclusion Criteria: - age > 20 years old - diagnosed as exacerbation of COPD - maximal inspiratory pressure (MIP) < 80 cmH2O Exclusion Criteria: - any clinical diagnosis that will influence the measurement, including any history of neuromyopathy - angina, acute myocardial infarction in the previous one month - pregnancy - participated in inspiratory muscle training program in the previous three months - any psychiatric or cognitive disorders, for example: Mini-Mental State Examination (MMSE) < 24, that will disturb the communication and cooperation of the study |
Country | Name | City | State |
---|---|---|---|
Taiwan | School and Graduate Institute of Physical Therapy of National Taiwan University | Taipei | Zhongzheng Dist |
Lead Sponsor | Collaborator |
---|---|
National Taiwan University Hospital |
Taiwan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Diaphragm muscle activation | The surface electromyography (EMG) signal was analyzed in the time domain, calculating root mean square (RMS) amplitude with a time constant of 30 mini seconds. A 1.5 seconds window of diaphragm muscle signals at peak pressure during maximal inspiratory pressure test were obtained and calculated as maximal effort. Diaphragm activation were calculated using mean RMS values of each threshold loaded breathing test, and then normalized to maximal effort (%EMGDia). | 10 minutes | |
Primary | Sternocleidomastoid muscle activation | The surface electromyography (EMG) signal was analyzed in the time domain, calculating root mean square (RMS) amplitude with a time constant of 30 mini seconds. A 1.5 seconds window of SCM muscle signals at peak pressure during maximal inspiratory pressure test were obtained and calculated as maximal effort. SCM activation were calculated using mean RMS values of each threshold loaded breathing test, and then normalized to maximal effort (%EMGSCM). | 10 minutes | |
Secondary | The mean median frequency of diaphragm and sternocleidomastoid muscle | The power spectrum is divided into two equal areas of the frequency value by median frequency to exam muscle fatigue. | 10 minutes | |
Secondary | Functional exercise capacity | Six-minute walking test will be performed to evaluate functional exercise capacity. | Considering time of test and recovery, it will be expected to take totally 10 minutes. | |
Secondary | Quality of life evaluation | St. George's Respiratory Questionnaire and COPD assessment test will be used to evaluate quality of life. | 10 minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03033251 -
High Flow Nasal Cannula Versus Non-Invasive Ventilation in Exacerbations of Chronic Obstructive Pulmonary Disease
|
N/A | |
Completed |
NCT03256604 -
A Sputum Screening Test to Rule-out Pneumonia at an Early Stage
|
N/A | |
Terminated |
NCT03153826 -
Determinants of Lower Limb Muscle Atrophy Induced During an Hospitalization for Exacerbation of COPD
|
N/A | |
Active, not recruiting |
NCT03432234 -
Respiratory Microbiome and COPD Exacerbations (RESMECOPD)
|
||
Recruiting |
NCT05704881 -
Monitoring of the End-tidal Carbon Dioxide (EtCO2) as a Severity Criterion in COPD Exacerbations
|
||
Recruiting |
NCT04319705 -
Anti-viral Effects of Azithromycin in Patients With Asthma and COPD
|
Phase 4 | |
Completed |
NCT05779384 -
The COPD Attack Study
|
||
Recruiting |
NCT04955080 -
REal-time Data Monitoring for Shared Adaptive, Multi-domain and Personalised Prediction and Decision Making for Long-term Pulmonary Care Ecosystems (RE-SAMPLE)
|
||
Completed |
NCT04122547 -
Efficacy of Roflumilast on Exacerbations in Patients With Non-cystic Fibrosis Bronchiectasis
|
Phase 3 | |
Completed |
NCT02972775 -
15-year Mortality After Hospitalization for Exacerbation of Chronic Obstructive Pulmonary Disease
|
||
Completed |
NCT05750810 -
Exacerbations and Their Outcomes International (EXACOS International)
|
||
Completed |
NCT05380869 -
POCT PCT in Outpatient LRTI
|
N/A |